PLoS ONE (May 2010)

Multiple phosphatidylinositol 3-kinases regulate vaccinia virus morphogenesis.

  • Shannon McNulty,
  • William Bornmann,
  • Jill Schriewer,
  • Chas Werner,
  • Scott K Smith,
  • Victoria A Olson,
  • Inger K Damon,
  • R Mark Buller,
  • John Heuser,
  • Daniel Kalman

DOI
https://doi.org/10.1371/journal.pone.0010884
Journal volume & issue
Vol. 5, no. 5
p. e10884

Abstract

Read online

Poxvirus morphogenesis is a complex process that involves the successive wrapping of the virus in host cell membranes. We screened by plaque assay a focused library of kinase inhibitors for those that caused a reduction in viral growth and identified several compounds that selectively inhibit phosphatidylinositol 3-kinase (PI3K). Previous studies demonstrated that PI3Ks mediate poxviral entry. Using growth curves and electron microscopy in conjunction with inhibitors, we show that that PI3Ks additionally regulate morphogenesis at two distinct steps: immature to mature virion (IMV) transition, and IMV envelopment to form intracellular enveloped virions (IEV). Cells derived from animals lacking the p85 regulatory subunit of Type I PI3Ks (p85alpha(-/-)beta(-/-)) presented phenotypes similar to those observed with PI3K inhibitors. In addition, VV appear to redundantly use PI3Ks, as PI3K inhibitors further reduce plaque size and number in p85alpha(-/-)beta(-/-) cells. Together, these data provide evidence for a novel regulatory mechanism for virion morphogenesis involving phosphatidylinositol dynamics and may represent a new therapeutic target to contain poxviruses.